Eyenuk Funding & Investors
Eyenuk, Inc. is a global artificial intelligence (AI) medical technology and services company and the leader in real-world AI Eye Screening for autonomous disease detection and AI Predictive Biomarkers™ for risk assessment and disease surveillance. Eyenuk’s first product, the EyeArt AI Eye Screening System, is the most extensively validated AI technology for autonomous detection of diabetic retinopathy. Eyenuk is on a mission to screen every eye in the world to ensure timely diagnosis of life- and vision-threatening diseases, including diabetic retinopathy, glaucoma, age-related macular degeneration, stroke risk, cardiovascular risk and Alzheimer’s disease.
eyenuk.comTotal Amount Raised: $47,400,000
Eyenuk Funding Rounds
Series Unknown
$6,200,000
Series Unknown Investors
AXA Investment ManagersGlobal Health Investment Fund (GHIF)Grant
$450,000
Grant
$300,000
Grant
$3,000,000
Seed
$1,500,000
Grant
$250,000
Grant
$2,500,000
Grant
$650,000
Series A
$26,000,000
Series A Investors
AXA Investment ManagersKendall Capital PartnersA&C Foelsgaard Alternativer ApSKOFA Healthcare InvestmentsT&W MedicalGrant
$300,000
Grant
$450,000
Series Unknown
$6,200,000
Series Unknown Investors
AXA Investment ManagersGlobal Health Investment Fund (GHIF)Grant
$1,800,000
Angel
$3,250,000
Angel
$1,500,000
Series A
$26,000,000
Series A Investors
AXA Investment ManagersKendall Capital PartnersA&C Foelsgaard Alternativer ApSKOFA Healthcare InvestmentsT&W Medical